CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 647080-647246 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T86958","span":{"begin":0,"end":166},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Azelastine nasal spray was effective in treating patients with moderate-to-severe SAR who remained symptomatic after treatment with either loratadine or fexofenadine."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T149","span":{"begin":0,"end":166},"obj":"Sentence"}],"text":"Azelastine nasal spray was effective in treating patients with moderate-to-severe SAR who remained symptomatic after treatment with either loratadine or fexofenadine."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5993","span":{"begin":23,"end":26},"obj":"Disease"}],"attributes":[{"id":"A5993","pred":"mondo_id","subj":"T5993","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"Azelastine nasal spray was effective in treating patients with moderate-to-severe SAR who remained symptomatic after treatment with either loratadine or fexofenadine."}